Regenxbio Inc (RGNX)
16.64
+0.44
(+2.72%)
USD |
NASDAQ |
May 02, 16:00
16.63
-0.01
(-0.06%)
Pre-Market: 20:00
Regenxbio Market Cap: 815.24M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 815.24M |
| May 01, 2024 | 793.68M |
| April 30, 2024 | 752.04M |
| April 29, 2024 | 786.33M |
| April 26, 2024 | 793.19M |
| April 25, 2024 | 786.82M |
| April 24, 2024 | 785.84M |
| April 23, 2024 | 778.99M |
| April 22, 2024 | 766.25M |
| April 19, 2024 | 768.70M |
| April 18, 2024 | 789.27M |
| April 17, 2024 | 834.35M |
| April 16, 2024 | 857.37M |
| April 15, 2024 | 882.85M |
| April 12, 2024 | 886.28M |
| April 11, 2024 | 931.84M |
| April 10, 2024 | 923.51M |
| April 09, 2024 | 931.35M |
| April 08, 2024 | 940.17M |
| April 05, 2024 | 939.19M |
| April 04, 2024 | 938.21M |
| April 03, 2024 | 992.10M |
| April 02, 2024 | 994.06M |
| April 01, 2024 | 1.055B |
| March 28, 2024 | 1.032B |
| Date | Value |
|---|---|
| March 27, 2024 | 1.087B |
| March 26, 2024 | 1.062B |
| March 25, 2024 | 1.058B |
| March 22, 2024 | 1.067B |
| March 21, 2024 | 1.102B |
| March 20, 2024 | 1.103B |
| March 19, 2024 | 1.097B |
| March 18, 2024 | 1.094B |
| March 15, 2024 | 1.087B |
| March 14, 2024 | 1.070B |
| March 13, 2024 | 1.101B |
| March 12, 2024 | 1.077B |
| March 11, 2024 | 1.119B |
| March 08, 2024 | 1.011B |
| March 07, 2024 | 1.032B |
| March 06, 2024 | 1.066B |
| March 05, 2024 | 1.093B |
| March 04, 2024 | 948.97M |
| March 01, 2024 | 941.42M |
| February 29, 2024 | 774.82M |
| February 28, 2024 | 884.11M |
| February 27, 2024 | 889.44M |
| February 26, 2024 | 814.80M |
| February 23, 2024 | 773.48M |
| February 22, 2024 | 807.25M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
536.04M
Minimum
Jan 30 2024
2.117B
Maximum
Jan 14 2021
1.242B
Average
1.266B
Median
Jan 06 2022
Market Cap Benchmarks
| Sarepta Therapeutics Inc | 12.34B |
| Amgen Inc | 149.19B |
| Gilead Sciences Inc | 81.46B |
| AbbVie Inc | 284.74B |
| Bristol-Myers Squibb Co | 88.58B |
Market Cap Related Metrics
| PS Ratio | 8.064 |
| Price to Book Value | 2.615 |
| Price | 16.64 |
| Earnings Yield | -36.18% |